- US-listed companies
- Elevance Health, Inc.
- Balance sheet
Elevance Health, Inc.ELV
Market cap
$81.1B
P/E ratio
| 2010/12 | 2011/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2024/12 | |
| Cash and cash equivalents | 1,789 | 2,202 | 1,582 | 2,152 | 2,114 | 4,075 | 3,609 | 3,934 | 4,937 | 5,741 | 4,880 | 7,387 | 8,288 |
| Marketable securities, current | 16,070 | 15,913 | 17,038 | 17,467 | 16,920 | 17,163 | 17,377 | 16,692 | 19,676 | 23,433 | 26,267 | 25,952 | 25,201 |
| Total cash & short-term investments | 17,858 | 18,115 | 18,620 | 19,619 | 19,034 | 21,238 | 20,986 | 20,626 | 24,613 | 29,174 | 31,147 | 33,339 | 33,489 |
| Total current assets | 26,141 | 27,097 | 29,746 | 32,229 | 30,862 | 34,315 | 36,263 | 34,321 | 39,033 | 45,751 | 51,122 | 55,617 | 58,942 |
| Property, plant and equipment, net | 1,156 | 1,418 | 1,802 | 1,944 | 2,020 | 1,978 | 2,175 | 2,735 | 3,133 | 3,483 | 3,919 | 4,316 | 4,652 |
| Marketable securities, non-current | 222 | 247 | 450 | 504 | 558 | 524 | 561 | 487 | 505 | 562 | 632 | 752 | 1,035 |
| Total non-current assets | 24,026 | 24,921 | 29,829 | 29,836 | 30,856 | 30,768 | 34,277 | 37,250 | 38,420 | 40,864 | 46,338 | 47,155 | 57,947 |
| Total assets | 50,167 | 52,019 | 59,575 | 62,065 | 61,718 | 65,083 | 70,540 | 71,571 | 77,453 | 86,615 | 97,460 | 102,772 | 116,889 |
| Long-term debt, current | 706 | 1,275 | 518 | 625 | - | 928 | 1,275 | 849 | 1,598 | 700 | 1,599 | 1,500 | 1,649 |
| Total current liabilities | 14,010 | 15,826 | 16,352 | 18,753 | 19,093 | 21,294 | 23,356 | 21,965 | 23,617 | 29,453 | 34,885 | 39,696 | 40,581 |
| Long-term debt, non-current | 8,148 | 8,421 | 13,574 | 14,127 | 15,325 | 14,359 | 17,382 | 17,217 | 17,787 | 19,335 | 21,157 | 22,349 | 29,218 |
| Total non-current liabilities | 12,345 | 12,905 | 18,458 | 19,060 | 19,581 | 18,688 | 20,681 | 21,065 | 22,108 | 23,963 | 26,447 | 26,682 | 34,882 |
| Total liabilities | 26,354 | 28,731 | 34,809 | 37,814 | 38,674 | 39,983 | 44,037 | 43,030 | 45,725 | 53,416 | 61,332 | 66,378 | 75,463 |
| Common stock and paid-in capital | 12,866 | 11,683 | 10,768 | 10,065 | 8,558 | 8,808 | 8,550 | 9,539 | 9,451 | 9,247 | 9,150 | 9,086 | 8,913 |
| Retained earnings | 10,722 | 11,491 | 13,814 | 14,014 | 14,779 | 16,561 | 18,054 | 19,988 | 22,573 | 23,802 | 27,088 | 29,724 | 33,549 |
| Stockholders' equity | 23,813 | 23,288 | 24,765 | 24,251 | 23,044 | 25,100 | 26,503 | 28,541 | 31,728 | 33,199 | 36,128 | 36,394 | 41,426 |
| Total debt | 8,854 | 9,740 | 14,092 | 14,644 | 15,325 | 15,287 | 18,657 | 18,066 | 19,385 | 20,035 | 22,756 | 23,849 | 30,867 |
| Net debt | -9,005 | -8,374 | -4,529 | -4,975 | -3,709 | -5,951 | -2,329 | -2,560 | -5,228 | -9,139 | -8,391 | -9,490 | -2,622 |
| D/E ratio (%) | 37.2 | 41.8 | 56.9 | 60.4 | 66.5 | 60.9 | 70.4 | 63.3 | 61.1 | 60.3 | 63 | 65.5 | 74.5 |